The effect of caffeine on subsequent sleep: A systematic review and meta-analysis.

Adenosine Sleep behaviours Sleep disruption Sleep recommendations Sleepiness Stimulant

Journal

Sleep medicine reviews
ISSN: 1532-2955
Titre abrégé: Sleep Med Rev
Pays: England
ID NLM: 9804678

Informations de publication

Date de publication:
06 2023
Historique:
received: 16 08 2022
revised: 22 01 2023
accepted: 26 01 2023
medline: 5 6 2023
pubmed: 5 3 2023
entrez: 4 3 2023
Statut: ppublish

Résumé

The consumption of caffeine in response to insufficient sleep may impair the onset and maintenance of subsequent sleep. This systematic review and meta-analysis investigated the effect of caffeine on the characteristics of night-time sleep, with the intent to identify the time after which caffeine should not be consumed prior to bedtime. A systematic search of the literature was undertaken with 24 studies included in the analysis. Caffeine consumption reduced total sleep time by 45 min and sleep efficiency by 7%, with an increase in sleep onset latency of 9 min and wake after sleep onset of 12 min. Duration (+6.1 min) and proportion (+1.7%) of light sleep (N1) increased with caffeine intake and the duration (-11.4 min) and proportion (-1.4%) of deep sleep (N3 and N4) decreased with caffeine intake. To avoid reductions in total sleep time, coffee (107 mg per 250 mL) should be consumed at least 8.8 h prior to bedtime and a standard serve of pre-workout supplement (217.5 mg) should be consumed at least 13.2 h prior to bedtime. The results of the present study provide evidence-based guidance for the appropriate consumption of caffeine to mitigate the deleterious effects on sleep.

Identifiants

pubmed: 36870101
pii: S1087-0792(23)00020-5
doi: 10.1016/j.smrv.2023.101764
pii:
doi:

Substances chimiques

Caffeine 3G6A5W338E
Coffee 0

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101764

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors do not have any conflicts of interest to disclose.

Auteurs

Carissa Gardiner (C)

School of Behavioural and Health Sciences, Australian Catholic University, Brisbane, Australia; Sports Performance, Recovery, Injury and New Technologies (SPRINT) Research Centre, Australian Catholic University, Brisbane, Australia.

Jonathon Weakley (J)

School of Behavioural and Health Sciences, Australian Catholic University, Brisbane, Australia; Sports Performance, Recovery, Injury and New Technologies (SPRINT) Research Centre, Australian Catholic University, Brisbane, Australia; Carnegie Applied Rugby Research (CARR) Centre, Institute of Sport, Physical Activity and Leisure, Leeds Beckett University, Leeds, UK. Electronic address: Jonathon.Weakley@acu.edu.au.

Louise M Burke (LM)

Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.

Gregory D Roach (GD)

Appleton Institute for Behavioural Science, Central Queensland University, Wayville, Australia.

Charli Sargent (C)

Appleton Institute for Behavioural Science, Central Queensland University, Wayville, Australia.

Nirav Maniar (N)

Sports Performance, Recovery, Injury and New Technologies (SPRINT) Research Centre, Australian Catholic University, Brisbane, Australia; School of Behavioural and Health Sciences, Australian Catholic University, Melbourne, Australia.

Andrew Townshend (A)

School of Behavioural and Health Sciences, Australian Catholic University, Brisbane, Australia; Sports Performance, Recovery, Injury and New Technologies (SPRINT) Research Centre, Australian Catholic University, Brisbane, Australia.

Shona L Halson (SL)

School of Behavioural and Health Sciences, Australian Catholic University, Brisbane, Australia; Sports Performance, Recovery, Injury and New Technologies (SPRINT) Research Centre, Australian Catholic University, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH